Perspective Therapeutics, Inc.
CATX- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0000728387
In the last 90 days, Perspective Therapeutics, Inc. insiders filed 0 open-market purchases and 5 sales; 131 institutions reported holding it in 13F filings for Q2 2026, worth $297.6M in total; no superinvestor holds it.
13F holders, Q1 2022
Institutional positions in Perspective Therapeutics, Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 39
- −6 vs. Q4 2021
- Shares held
- 15.9M
- −1.55M (−8.8%) vs. Q4 2021
- Total value
- $5.79M
- −$993.2K (−14.6%) vs. Q4 2021
- New holders
- 3
- 10 more added
- Sold out
- 9
- 10 more reduced
Compare with Q4 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting CATX on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 131 | $297.6M |
| Q1 2026 | 138 | $333.1M |
| Q4 2025 | 117 | $105.0M |
| Q3 2025 | 105 | $150.1M |
| Q2 2025 | 98 | $146.3M |
| Q1 2025 | 112 | $96.4M |
| Q4 2024 | 135 | $150.7M |
| Q3 2024 | 127 | $654.9M |
| Q2 2024 | 105 | $384.9M |
| Q1 2024 | 104 | $294.6M |
| Q4 2023 | 52 | $14.7M |
| Q3 2023 | 49 | $9.99M |
| Q2 2023 | 50 | $22.0M |
| Q1 2023 | 42 | $17.8M |
| Q4 2022 | 48 | $4.26M |
| Q3 2022 | 35 | $3.70M |
| Q2 2022 | 43 | $5.19M |
| Q1 2022 | 39 | $5.79M |
| Q4 2021 | 45 | $6.78M |
| Q3 2021 | 43 | $9.99M |
| Q2 2021 | 48 | $13.9M |
| Q1 2021 | 57 | $20.2M |
Institutions, Q1 2022
Shares, value and share of portfolio for each institution holding Perspective Therapeutics, Inc.; share changes are against Q4 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| UBS Group AG | 680 | $0 | 0.00% | −121,263−99.4% | Reduced |
| FNY Investment Advisers, LLC | 600 | $0 | 0.00% | −210−25.9% | Reduced |
| Arcadia Investment Advisors LLC | 222 | $81 | 0.00% | 00.0% | Unchanged |
| TD Waterhouse Canada Inc. | 2,000 | $730 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 6,254 | $2.00K | 0.00% | +103+1.7% | Added |
| JNBA Financial Advisors | 5,000 | $2.00K | 0.00% | 00.0% | Unchanged |
| Jane Street Group, LLC | 12,031 | $4.00K | 0.00% | −30,316−71.6% | Reduced |
| Capital Advisors Inc | 10,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| Wealth Effects LLC | 10,000 | $4.00K | 0.00% | 00.0% | Unchanged |
| Douglass Winthrop Advisors, LLC | 10,000 | $4.00K | 0.00% | +10,000 | New |
| Auxier Asset Management | 14,218 | $5.00K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 13,795 | $5.00K | 0.00% | +5,718+70.8% | Added |
| Victory Capital Management Inc | 20,089 | $6.00K | 0.00% | −555−2.7% | Reduced |
| Raymond James Financial Services Advisors, Inc. | 17,500 | $6.00K | 0.00% | 00.0% | Unchanged |
| Susquehanna International Group, LLP | 18,188 | $7.00K | 0.00% | −146,893−89.0% | Reduced |
| TMD Wealth Management, LLC | 20,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| Ameriprise Financial Inc | 18,000 | $7.00K | 0.00% | 00.0% | Unchanged |
| Commonwealth Equity Services, LLC | 26,284 | $9.00K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 25,134 | $9.00K | 0.00% | −558−2.2% | Reduced |
| Bullseye Investment Management, LLC | 25,000 | $9.00K | 0.01% | +25,000 | New |
| Bremer Bank National Association | 29,411 | $11.0K | 0.00% | 00.0% | Unchanged |
| Millennium Management LLC | 38,126 | $14.0K | 0.00% | +16,687+77.8% | Added |
| Cerity Partners LLC | 40,000 | $15.0K | 0.00% | 00.0% | Unchanged |
| Crestwood Advisors Group LLC | 54,824 | $20.0K | 0.00% | 00.0% | Unchanged |
| Two Sigma Advisers, LP | 65,800 | $24.0K | 0.00% | +26,200+66.2% | Added |
| Bank of New York Mellon Corp | 77,229 | $28.0K | 0.00% | −22,000−22.2% | Reduced |
| Morgan Stanley | 90,630 | $33.0K | 0.00% | +14,397+18.9% | Added |
| Citadel Advisors LLC | 126,940 | $46.0K | 0.00% | +126,940 | New |
| Creative Planning | 129,500 | $47.0K | 0.00% | +15,000+13.1% | Added |
| Bridgeway Capital Management, LLC | 184,000 | $67.0K | 0.00% | 00.0% | Unchanged |
| Northern Trust Corp | 261,549 | $95.0K | 0.00% | 00.0% | Unchanged |
| Renaissance Technologies LLC | 417,315 | $151.0K | 0.00% | −563,591−57.5% | Reduced |
| Taylor & Morgan Wealth Management, LLC | 550,000 | $200.0K | 0.16% | +210,000+61.8% | Added |
| State Street Corp | 553,619 | $201.0K | 0.00% | +34,577+6.7% | Added |
| Bard Associates Inc | 669,200 | $243.0K | 0.09% | +50,000+8.1% | Added |
| Geode Capital Management, LLC | 1,119,070 | $406.0K | 0.00% | 00.0% | Unchanged |
| BlackRock Inc. | 2,439,218 | $885.0K | 0.00% | +9450.0% | Added |
| Perkins Capital Management Inc | 2,798,500 | $1.02M | 0.83% | −2,500−0.1% | Reduced |
| Vanguard Group Inc | 6,047,815 | $2.20M | 0.00% | −18,377−0.3% | Reduced |
| Highland Private Wealth Management | 0 | $0 | 0.00% | −972,038−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −61,500−100.0% | Sold out |
| Charles Schwab Investment Management Inc | 0 | $0 | 0.00% | −55,471−100.0% | Sold out |
| AdvisorNet Financial, Inc | 0 | $0 | 0.00% | −44,560−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −40,836−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −1,500−100.0% | Sold out |
| Horizon Financial Services, LLC | 0 | $0 | 0.00% | −350−100.0% | Sold out |
| Bank of America Corp | 0 | $0 | 0.00% | −206−100.0% | Sold out |
| Chilton Capital Management LLC | 0 | $0 | 0.00% | −500−100.0% | Sold out |